B. Riley Financial, Inc. Verastem, Inc. Transaction History

B. Riley Financial, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$1.25 - $3.14 $73,625 - $184,946	-58,900 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$2.79 - $4.09 $319,569 - $468,472	-114,541 Reduced 66.04%	58,900 $174,000
Q4 2018 Feb 07, 2019	BUY	$3.23 - $7.01 $375,293 - $814,491	116,190 Added 202.95%	173,441 $583,000
Q3 2018 Nov 13, 2018	BUY	$6.86 - $9.97 $392,741 - $570,792	57,251 New	57,251 $415,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $565M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of B. Riley Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on B. Riley Financial, Inc. with notifications on news.